iSpecimen Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
-$0.66next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly156K
Quarterly Net Loss Quarterly-2.3M
Stockholders' Equity Quarterly814K
Cash and Cash Equivalents Quarterly2.8M
Watch Items
- Nasdaq Stockholders' Equity ComplianceTrigger: Below $2,500,000Action: Submit a compliance plan to Nasdaq within 45 days of the May 29, 2026 notice to outline steps to regain compliance.
- Going Concern StatusTrigger: Persistent negative working capital and cash burnAction: Monitor cash runway, execute cost-reduction initiatives, and pursue additional equity or debt financing.
Research as of 20 Jun 2026